TGFB1 and neoplasm: Given the context-dependent role of TGF-β within the tumor microenvironment, as either a tumor suppressor or a tumor promoter, it is likely that multiple mechanisms of therapy resistance are limiting the clinical utility of this targeted therapeutic strategy.